News Powered By AI
News Powered By AI
US stock futures rose modestly amid Middle East tensions and strong earnings reports, with Palantir surging 14% after posting robust commercial revenue growth.
McDonald’s reported mixed second-quarter results as U.S. same-store sales growth slowed to 0.8%, though global performance remained steady and the company promoted a new U.S. division leader.
The yen slipped but retained most gains from last week’s joint U.S.-Japan intervention, trading at 157.8 per dollar while remaining well above July’s 40-year low of 163.99.
South Korean retail investors launched a campaign seeking an extraordinary shareholders’ meeting at Samsung Electronics to push for a $32 billion share buyback and limits on performance bonuses.
Fresenius Medical Care shares fell 8.0% despite beating second-quarter earnings forecasts, as investors focused on declining U.S. patient treatment volumes and unchanged full-year guidance.
Merck reported better-than-expected second-quarter revenue of $16.61 billion, driven by strong Keytruda cancer drug sales, and raised its full-year forecast.
